Evidence map›Paper›PMID 35726418›Full record

ArticleInfectious disorders drug targets2022

Prevalence of Hepatitis in Prisoners: A Systematic Review of Current Evidence.

Salar Pashangzadeh, SeyedAhmad SeyedAlinaghi, Omid Dadras, Zahra Pashaei, Mahdi Soleymanzadeh, Alireza Barzegary, Pegah Mirzapour, Farzin Vahedi, Amirata Fakhfouri, Tayebeh Noori and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Infectious disorders drug targets, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 3 countries.

Salar PashangzadehIranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.
SeyedAhmad SeyedAlinaghiIranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.
Omid DadrasSection Global Health and Rehabilitation, Western Norway University and Applied Sciences, Bergen, Norway.
Zahra PashaeiIranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.
Mahdi SoleymanzadehSchool of Medicine, Ophthalmology Resident at Farabi Hospital, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
Alireza BarzegarySchool of Medicine, Islamic Azad University, Tehran, Iran.
Pegah MirzapourIranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.
Farzin VahediSchool of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Amirata FakhfouriSchool of Medicine, Islamic Azad University, Tehran, Iran.
Tayebeh NooriDepartment of Health Information Technology, Zabol University of Medical Sciences, Zabol, Iran.
Seyed Mohammad Hossein IraniDepartment of Health Information Technology, Khalkhal University of Medical Sciences, Khalkhal, Iran.
Esmaeil MehraeenDepartment of Health Information Technology, Khalkhal University of Medical Sciences, Khalkhal, Iran.ORCID 0000-0003-4108-2973
Shayesteh JahanfarDepartment of Public Health and Community Medicine, Tufts University School of Medicine, Massachusetts, Boston, USA.
Iranian Institute for Health Sciences Research · IRIslamic Azad University, Tehran · IRLorestan University of Medical Sciences · IRBoston University · USFarabi Hospital · IRTehran University of Medical Sciences · IRWestern Norway University of Applied Sciences · NOZabol University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPrisoners represent high-risk behaviors such as injecting drug use, sharing syringes, tattooing, and unprotected sexual intercourse. The authors aimed to study the prevalence of hepatitis B, hepatitis C, and hepatitis D in the prisoners.

methodsWe conducted a systematic search using the keywords in online databases of PubMed, Web of Science, Scopus, and Science Direct. Two independent researchers examined the quality of the articles and the probable risk of bias. The most relevant articles by title and abstract were retrieved. Finally, the full text of selected articles was read, and the critical findings were extracted.

resultsReviews of 23 studies showed that most prisoners are susceptible to hepatitis B and hepatitis C. One study also indicated that prisoners could be infected with hepatitis A and hepatitis E. The most common routes of hepatitis transmission in prisons were intravenous drug use, needle sharing, tattooing, and unsafe sex with multiple sexual partners.

conclusionHigh-risk sexual behaviors, shared contaminated needles for IV drug injection, and tattooing are the principal routes of hepatitis transmission among prison inmates. Hepatitis treatment is feasible and could be useful for infected prisoners undergoing a well-designed treatment program.

Indexed as

Hepatitis Bhepatitis Chepatitis Dinjecting drugliver diseaseprisoners

Identifiers

PMID35726418
OpenAlexW4283261010

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.